חזרה לתוצאות החיפוש

Tocilizumab Discontinuation Versus Dose Reduction for Patients With Well-Controlled Giant Cell Arteritis

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE2

מצבים רפואיים

Giant Cell Arteritis (GCA)

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים

  • Emory University School of Medicine: Division of Rheumatology, Atlanta, Georgia, United States

    Contact: Study coordinator (Chris Chin) · chris.chi.chin@emory.edu · 404-712-2874
    Contact: Principal Investigator (Athanasios Tiliakos, DO)

  • Northwestern University, Chicago, Illinois, United States

    Contact: Study coordinator (John Seagrist) · john.seagrist@northwestern.edu · 312-503-0565
    Contact: Principal Investigator (Anisha Dua, MD)

  • Johns Hopkins Hospital: Division of Rheumatology Vasculitis Center, Baltimore, Maryland, United States

    Contact: Study coordinator (Hannah Smith) · Hsmith97@jh.edu · 410-550-2044
    Contact: Principal Investigator (Brendan Antiochos)

  • Massachusetts General Hospital: Rheumatology, Allergy and Immunology, Center for Immunology and Inflammatory Diseases, Boston, Massachusetts, United States

    Contact: Study coordinator (Joseph Sadok) · jsadok@mgh.harvard.edu · 617-724-8048
    Contact: Principal Investigator (Sebastian Unizony, MD)

  • Northwell Health: Division of Rheumatology and Allergy-Clinical Immunology, Great Neck, New York, United States

    Contact: Study coordinator (Mohini Doobay) · MDoobay1@northwell.edu · 516-708-2546
    Contact: Principal Investigator (Lara El Khoury, MD)

  • Hospital for Special Surgery, New York: Division of Rheumatology, New York, New York, United States

  • University of Pittsburgh Medical Center: Division of Rheumatology and Clinical Immunology, Pittsburgh, Pennsylvania, United States

    Contact: Study coordinator (Emily Matone) · emm518@pitt.edu · 412-465-0242
    Contact: Principal Investigator (Robyn E. Domsic, MD)
מובילי המחקר

  • Sebastian H Unizony, M.D.

    Study Chair

    Massachusetts General Hospital: Rheumatology, Allergy and Immunology, Center for Immunology and Inflammatory Diseases

צפייה במקור ב־ClinicalTrials.gov(נפתח בחלון חדש)